Adenovir Pharma
EKC - a highly contagious infectious disease | Adenovir Pharma.
Launch date
Employees
Market cap
-
Enterprise valuation
€3—4m (Dealroom.co estimates Jun 2010.)
Company register number 556745-9986
Göteborgs Stad Västra Götaland County (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|
Revenues | <1m | - | - | - | - |
EBITDA | - | - | (<1m) | (<1m) | (<1m) |
Profit | (<1m) | (1.6m) | (4.4m) | (<1m) | (<1m) |
% profit margin | (1017 %) | - | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$790k | Early VC | ||
Total Funding | €718k |
Related Content
Recent News about Adenovir Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.